Treatment of moderately to severely active rheumatoid arthritis. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Joints Synovial Membrane Synovial Fluid Finger Joint Metacarpophalangeal Joint Wrist Joint Foot Joints Knee Joint Hand Joints Cells, Cultured Tarsal Joints Fibroblasts T-Lymphocytes Hand Metatarsophalangeal Joint Cartilage, Articular Toe Joint

Organisms2

Mice, Inbred DBA Rats, Inbred Lew

Diseases27

Arthritis, Rheumatoid Arthritis Arthritis, Experimental Arthritis, Infectious Arthritis, Juvenile Arthritis, Psoriatic Arthritis, Reactive Synovitis Osteoarthritis Disease Progression Rheumatoid Nodule Rheumatic Diseases Spondylitis, Ankylosing Arthritis, Gouty Autoimmune Diseases Lupus Erythematosus, Systemic Joint Diseases Genetic Predisposition to Disease Spondylarthropathies Felty Syndrome Hand Deformities, Acquired Tenosynovitis Sjogren's Syndrome Inflammation Pain Disease Models, Animal Foot Deformities, Acquired

Chemicals and Drugs45

Antirheumatic Agents Methotrexate Isoxazoles Sulfasalazine Rheumatoid Factor Antibodies, Monoclonal Hydroxychloroquine Gold Sodium Thiomalate Tumor Necrosis Factor-alpha Antibodies, Monoclonal, Humanized Receptors, Tumor Necrosis Factor Immunoglobulin G Anti-Inflammatory Agents, Non-Steroidal Prednisolone Antibodies, Monoclonal, Murine-Derived Immunoconjugates Glucocorticoids C-Reactive Protein Placebos Immunosuppressive Agents Autoantibodies Peptides, Cyclic HLA-DRB1 Chains HLA-DR4 Antigen HLA-DR Antigens Collagen Type II Citrulline Organogold Compounds Anti-Inflammatory Agents Penicillamine Biological Markers Cytokines Auranofin Immunoglobulin M Protein Tyrosine Phosphatase, Non-Receptor Type 22 Aurothioglucose Autoantigens Interleukin-6 Antigen-Antibody Complex Collagen Antibodies, Antinuclear Interleukin-1 Interleukin-17 Interleukin 1 Receptor Antagonist Protein Biological Products

Analytical, Diagnostic and Therapeutic Techniques and Equipment20

Drug Therapy, Combination Double-Blind Method Severity of Illness Index Arthritis, Experimental Blood Sedimentation Treatment Outcome Arthrography Injections, Subcutaneous Placebos Disability Evaluation Drug Administration Schedule Follow-Up Studies Prospective Studies Injections, Intra-Articular Case-Control Studies Enzyme-Linked Immunosorbent Assay Cohort Studies Disease Models, Animal Pain Measurement Biological Therapy

Psychiatry and Psychology1

Phenomena and Processes4

Dose-Response Relationship, Drug Genetic Predisposition to Disease Pain Time Factors

Disciplines and Occupations1

Anthropology, Education, Sociology and Social Phenomena1

Health Care8

Double-Blind Method Severity of Illness Index Treatment Outcome Health Status Follow-Up Studies Prospective Studies Case-Control Studies Cohort Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Health Care

Arthritis, Rheumatoid Antirheumatic Agents Methotrexate Arthritis Isoxazoles Sulfasalazine Joints Drug Therapy, Combination Double-Blind Method Synovial Membrane Severity of Illness Index Arthritis, Experimental Blood Sedimentation Rheumatoid Factor Synovial Fluid Treatment Outcome Antibodies, Monoclonal Hydroxychloroquine Gold Sodium Thiomalate Arthritis, Infectious Arthrography Finger Joint Arthritis, Juvenile Tumor Necrosis Factor-alpha Antibodies, Monoclonal, Humanized Receptors, Tumor Necrosis Factor Immunoglobulin G Arthritis, Psoriatic Injections, Subcutaneous Anti-Inflammatory Agents, Non-Steroidal Prednisolone Antibodies, Monoclonal, Murine-Derived Arthritis, Reactive Immunoconjugates Glucocorticoids Synovitis C-Reactive Protein Osteoarthritis Placebos Dose-Response Relationship, Drug Immunosuppressive Agents Disease Progression Disability Evaluation Drug Administration Schedule Health Status Rheumatoid Nodule Metacarpophalangeal Joint Autoantibodies Follow-Up Studies Prospective Studies Rheumatology Peptides, Cyclic Rheumatic Diseases HLA-DRB1 Chains Wrist Joint Mice, Inbred DBA HLA-DR4 Antigen HLA-DR Antigens Collagen Type II Citrulline Spondylitis, Ankylosing Arthritis, Gouty Autoimmune Diseases Organogold Compounds Foot Joints Lupus Erythematosus, Systemic Anti-Inflammatory Agents Penicillamine Knee Joint Biological Markers Injections, Intra-Articular Case-Control Studies Hand Joints Joint Diseases Rats, Inbred Lew Enzyme-Linked Immunosorbent Assay Cytokines Genetic Predisposition to Disease Spondylarthropathies Auranofin Cells, Cultured Felty Syndrome Tarsal Joints Hand Deformities, Acquired Fibroblasts Tenosynovitis T-Lymphocytes Sjogren's Syndrome Immunoglobulin M Protein Tyrosine Phosphatase, Non-Receptor Type 22 Aurothioglucose Inflammation Autoantigens Interleukin-6 Cohort Studies Antigen-Antibody Complex Pain Disease Models, Animal Collagen Hand

No FAQ available that match "treatment of moderately to severely active rheumatoid arthritis"